Biohaven

Biohaven Tax Expense

The Income Tax Expense of Biohaven (BHVN) as of Nov 18, 2026 is 1.44 M USD. In the previous year, Income Tax Expense was 735,000.00 USD — a change of 96.19% (higher).

Tax Expense

1.44 MUSD

YoY

96.19%

Last updated:

Income Tax Expense of Biohaven is 2025 1.44 M USD. Income Tax Expense of Biohaven was 2024 735,000.00 USD. It decreases by 96.19% higher compared to the previous year.

The Biohaven Tax Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tax Expense
Date
Tax Expense
Jan 1, 2018
467,000.00 USD
Jan 1, 2019
419,000.00 USD
Jan 1, 2020
10.23 M USD
Jan 1, 2021
5.07 M USD
Jan 1, 2022
438,000.00 USD
Jan 1, 2023
-1.38 M USD
Jan 1, 2024
735,000.00 USD
Jan 1, 2025
1.44 M USD
The Biohaven Tax Expense history
YEARTax ExpenseYoY
1.44 MUSD+96.19%
735,000.00USD-153.15%
-1.38 MUSD-415.75%
438,000.00USD-91.37%
5.07 MUSD-50.40%
10.23 MUSD+2,340.81%
419,000.00USD-10.28%
467,000.00USD-53.58%
1.01 MUSD+1,017.78%
90,000.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biohaven Stock analysis

What does Biohaven do? Biohaven Pharmaceutical Holding Co. Ltd. generates revenue through the research and development of late-stage product candidates targeting neurological diseases and rare disorders. The company utilizes its glutamate platform to advance clinical-stage compounds for various indications, including trigriluzole for obsessive-compulsive disorder, spinocerebellar ataxia, and Alzheimer's disease. Additionally, the firm develops BHV-0223 for amyotrophic lateral sclerosis and BHV-5000 for conditions such as Rett syndrome, neuropathic pain, and treatment-resistant depression. The business model focuses on identifying and developing clinical-stage compounds that target orphan neurologic indications and other neurological pathways, with the company currently employing 825 full-time employees in New Haven, Connecticut. Biohaven is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biohaven stock

Income Tax Expense of Biohaven is 1.44 M USD in 2025.

Income Tax Expense of Biohaven changed from 735,000.00 USD to 1.44 M USD, representing a 96.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Income Tax Expense Biohaven since 2006 – with annual values, charts, and detailed analysis.

Tax expense represents the total income taxes owed. It reflects the company's tax obligations and effective tax rate.

Income Tax Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Income Tax Expense's Biohaven historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Biohaven

All Key Metrics — Biohaven